Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Rey

Showing results (31-40 of 109) with videos related to

Pageof 11
Sort By:
AIDS (London, England)|July 21, 2017
Epidemiology of autoimmune and inflammatory diseases in a French nationwide HIV cohortDelphine Lebrun, Maxime Hentzien, Lise Cuzin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2026
Switch to BIC/TAF/FTC or DTG + TDF/FTC in virologically suppressed PWH: outcomes in real-world setting with and without tenofovir resistanceAlain Makinson, Firouze Bani-Sadr, Romain Palich, et al.
Plos One|March 7, 2024
Questioning the "Ease" in disease: Was living with HIV a burden or boost during the first wave of Covid-19 in France? A qualitative study (COVIDHIV)Guillaume Roucoux, Frédérique Thonon, David Zucman, et al.
AIDS Research and Human Retroviruses|September 27, 2023
No Association Between HLA-B*57:01 and Prevalence and/or Outcome of Progressive Multifocal Leukoencephalopathy in a French Nationwide Human Immunodeficiency Virus CohortSolène Secher, Maxime Hentzien, Lise Cuzin, et al.
BMJ Open|February 21, 2019
HIV-related excess mortality and age-related comorbidities in patients with HIV aged ≥60: a relative survival analysis in the French Dat'AIDS cohortMaxime Hentzien, Moustapha Dramé, Cyrille Delpierre, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 24, 2006
Virologic response of zidovudine, lamivudine, and tenofovir disoproxil fumarate combination in antiretroviral-naive HIV-1-infected patientsDavid Rey, Magali Krebs, Marialuisa Partisani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2024
Two Cases of Viral Re-suppression After M184V + R263K Selection on Dolutegravir/Lamivudine Without Treatment ModificationAxel Ursenbach, Yvon Ruch, Baptiste Hoellinger, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 27, 2012
Is total community viral load a robust predictive marker of the efficacy of the TasP strategy?Sandrine Henard, Eliette Jeanmaire, Yohan Nguyen, et al.
Genes and Immunity|August 8, 2020
A FcɣRIIa polymorphism has a HLA-B57 and HLA-B27 independent effect on HIV disease outcomeRaphael Carapito, Luzia Mayr, Anne Molitor, et al.
JAMA Internal Medicine|April 12, 2016
Long-term Immune Response to Hepatitis B Virus Vaccination Regimens in Adults With Human Immunodeficiency Virus 1: Secondary Analysis of a Randomized Clinical TrialOdile Launay, Arielle R Rosenberg, David Rey, et al.
Pageof 11

Showing results (31-40 of 109) with videos related to

Sort By:
Pageof 11
AIDS (London, England)|July 21, 2017
Epidemiology of autoimmune and inflammatory diseases in a French nationwide HIV cohortDelphine Lebrun, Maxime Hentzien, Lise Cuzin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2026
Switch to BIC/TAF/FTC or DTG + TDF/FTC in virologically suppressed PWH: outcomes in real-world setting with and without tenofovir resistanceAlain Makinson, Firouze Bani-Sadr, Romain Palich, et al.
Plos One|March 7, 2024
Questioning the "Ease" in disease: Was living with HIV a burden or boost during the first wave of Covid-19 in France? A qualitative study (COVIDHIV)Guillaume Roucoux, Frédérique Thonon, David Zucman, et al.
AIDS Research and Human Retroviruses|September 27, 2023
No Association Between HLA-B*57:01 and Prevalence and/or Outcome of Progressive Multifocal Leukoencephalopathy in a French Nationwide Human Immunodeficiency Virus CohortSolène Secher, Maxime Hentzien, Lise Cuzin, et al.
BMJ Open|February 21, 2019
HIV-related excess mortality and age-related comorbidities in patients with HIV aged ≥60: a relative survival analysis in the French Dat'AIDS cohortMaxime Hentzien, Moustapha Dramé, Cyrille Delpierre, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 24, 2006
Virologic response of zidovudine, lamivudine, and tenofovir disoproxil fumarate combination in antiretroviral-naive HIV-1-infected patientsDavid Rey, Magali Krebs, Marialuisa Partisani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2024
Two Cases of Viral Re-suppression After M184V + R263K Selection on Dolutegravir/Lamivudine Without Treatment ModificationAxel Ursenbach, Yvon Ruch, Baptiste Hoellinger, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 27, 2012
Is total community viral load a robust predictive marker of the efficacy of the TasP strategy?Sandrine Henard, Eliette Jeanmaire, Yohan Nguyen, et al.
Genes and Immunity|August 8, 2020
A FcɣRIIa polymorphism has a HLA-B57 and HLA-B27 independent effect on HIV disease outcomeRaphael Carapito, Luzia Mayr, Anne Molitor, et al.
JAMA Internal Medicine|April 12, 2016
Long-term Immune Response to Hepatitis B Virus Vaccination Regimens in Adults With Human Immunodeficiency Virus 1: Secondary Analysis of a Randomized Clinical TrialOdile Launay, Arielle R Rosenberg, David Rey, et al.
Pageof 11